All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @coach.petrovmckinnon on Instagram · 63s|Watch on Instagram
Full video transcriptClick to expand

Auto-generated transcript of @coach.petrovmckinnon's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00For the first time, we had the Panznietle,
  2. 0:02and the tenants, who were here,
  3. 0:05and it was a whole different place.
  4. 0:06I think it was the first place that I thought was the first place
  5. 0:10to be a part of the Panznietle.
  6. 0:11My name is John, I'm a manager for Panznietle,
  7. 0:14and I'm a professor of Panznietle,
  8. 0:17and I'm a professor here in the studio.
  9. 0:19I'm a professor of Panznietle,
  10. 0:22and I'm an associate with the Panznietle and the Panzietle.
  11. 0:25I'm a professor and a professor of Panzietle.
  12. 0:27You'll see the color line up a little like a TPA.
  13. 0:30So there is a body that is freelymmied on the sides of the body.
  14. 0:35So the body is a very sharp and absolutely sharp,
  15. 0:38so that's how you prevent the heavy implants.
  16. 0:42This body is a very tight spot and you can't find any muscle.
  17. 0:45So I've been making it for some time.
  18. 0:47And I'd like toi s go on,
  19. 0:49since it is a little bit of motion.
  20. 0:50So you can see what are the English muscles that you'll be trying to do.
  21. 0:53and then they should be able to see what's going on in the future.
  22. 0:59It's a very good answer.
  23. 1:00Like the oven to an oven to an oven to an oven.

This peptide therapy influencer's TB-500 and BPC-157 claims

Pierre-Olivier McKinnon

Instagram creator

127.5K viewsView on Instagram

Quick answer

This video promotes TB-500 and BPC-157 for tendon injury recovery and body composition in a fitness context, using a commercial promo code. Both peptides have shown soft tissue repair effects in preclinical animal models, but neither has completed peer-reviewed, placebo-controlled human clinical trials sufficient to establish safety or efficacy. Neither compound is approved by the FDA or Health Canada for any therapeutic indication.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For This peptide therapy influencer's TB-500 and BPC-157 claims, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "This peptide therapy influencer's TB-500 and BPC-157 claims" from Pierre-Olivier McKinnon. We read the clip as a Peptide social video fact-checks claim about BPC-157, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This video promotes TB-500 and BPC-157 for tendon injury recovery and body composition in a fitness context, using a commercial promo code.

The reason this review is not generic is the source wording and the canonical claim label "peptides gym fitness fitfam prepcoach entrainement musculation." In this clip, the useful excerpt is: "For the first time, we had the Panznietle, and the tenants, who were here, and it was a whole different place." That wording changes the review because it points to BPC-157 safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. BPC-157 still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

TB-500 has been banned by the World Anti-Doping Agency since 2011.
People who land here are usually comparing the BPC-157 claim with gym, fitness, and fitfam.
The strongest next step is to compare the claim with FormBlends' BPC-157 guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This video promotes TB-500 and BPC-157 for tendon injury recovery and body composition in a fitness context, using a commercial promo code.

FormBlends verdict

BPC-157 safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video promotes TB-500 and BPC-157 for tendon injury recovery and body composition in a fitness context, using a commercial promo code. Both peptides have shown soft tissue repair effects in preclinical animal models, but neither has completed peer-reviewed, placebo-controlled human clinical trials sufficient to establish safety or efficacy. Neither compound is approved by the FDA or Health Canada for any therapeutic indication.
  • BPC-157 tendon healing data comes almost entirely from rat models (Staresinic et al., 2003, Journal of Orthopaedic Research). No placebo-controlled human trial has replicated these results.
  • TB-500 has been banned by the World Anti-Doping Agency since 2011. Competitive athletes using it risk disqualification regardless of perceived recovery benefits.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • BPC-157 tendon healing data comes almost entirely from rat models (Staresinic et al., 2003, Journal of Orthopaedic Research). No placebo-controlled human trial has replicated these results.
  • TB-500 has been banned by the World Anti-Doping Agency since 2011. Competitive athletes using it risk disqualification regardless of perceived recovery benefits.
  • A 2022 JAMA Internal Medicine analysis found label inaccuracy in a significant proportion of unregulated peptide products, meaning you often cannot verify what you are actually injecting.
  • Eccentric and heavy slow resistance training protocols have stronger human evidence for tendinopathy recovery than any peptide compound currently available (Beyer et al., 2015, Scandinavian Journal of Medicine and Science in Sports).
  • Neither BPC-157 nor TB-500 is approved by the FDA or Health Canada for any human therapeutic indication. Use outside a licensed clinical trial is off-label at minimum, and illegal to sell as a therapeutic in many jurisdictions.
  • Promo codes tied to peptide sales represent a commercial relationship. Factor that into how you weigh the information being presented alongside the product.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @coach.petrovmckinnon actually say?

Honestly, this is a difficult video to fact-check because the transcript is largely unintelligible. The auto-generated captions appear to have failed significantly, producing phrases like "Panznietle" repeatedly and nonsensical lines such as "like the oven to an oven to an oven." What we can work with is the caption, which tags both TB-500 and BPC-157 alongside hashtags for tendinitis, muscle mass, and fat loss, and includes a promotional code for atplab.com.

Based on the caption context, this video appears to be promoting peptide therapy, specifically TB-500 (Thymosin Beta-4) and BPC-157, for tendon recovery and body composition. The creator identifies as a prep coach and fitness trainer. We're fact-checking the implied claims based on the product category and promotional framing, since the spoken content cannot be reliably transcribed.

Does the science back this up?

The short answer is: partially, in animals, rarely in humans, and never in a regulatory-approved context. The enthusiasm around BPC-157 and TB-500 in fitness communities runs well ahead of the clinical evidence.

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. Animal studies, particularly in rats, have shown accelerated tendon and ligament healing. A frequently cited study by Staresinic et al. (2003, Journal of Orthopaedic Research) found improved Achilles tendon healing in rats treated with BPC-157. That sounds promising. The problem is that no peer-reviewed, placebo-controlled human clinical trial has confirmed these effects in people. The jump from rat tendon to your shoulder rotator cuff is not small.

TB-500, or Thymosin Beta-4, has similarly compelling animal data. Chang et al. (2011, Journal of Investigative Dermatology) demonstrated wound healing acceleration in mice. Again, human trials are sparse and largely underpowered. Neither compound is FDA-approved for any indication. Both are classified as research chemicals, and compounded versions sold online exist in a regulatory grey zone at best.

What did they get wrong (or right)?

We cannot fairly say the creator got specific facts wrong in spoken content we cannot read. What we can evaluate is the promotional framing. Pairing a promo code with peptides that have no approved human therapeutic use is a pattern worth flagging.

To give some credit: the hashtag focus on tendinitis is at least thematically consistent with where the most promising preclinical research on BPC-157 exists. Tendon injuries are genuinely difficult to treat. Physio takes months. Corticosteroid injections carry risks. It is understandable why athletes look elsewhere. The frustration is real, even if the solution being sold is not well-evidenced.

What is misleading is presenting these compounds alongside a supplement storefront as though they are established tools. They are not. The World Anti-Doping Agency banned TB-500 in 2011. That detail tends not to make it into fitness influencer captions.

What should you actually know?

If you are dealing with tendinitis or a soft tissue injury, the evidence hierarchy looks nothing like what peptide marketing suggests. Physical therapy, specifically eccentric loading protocols, has the strongest evidence base for conditions like Achilles tendinopathy. A 2015 meta-analysis by Beyer et al. (Scandinavian Journal of Medicine and Science in Sports) found heavy slow resistance training comparable to, and in some outcomes superior to, standard eccentric protocols.

Peptides like BPC-157 and TB-500 are not approved by Health Canada or the FDA for human use outside of clinical trials. Purchasing compounded versions online carries real risks: contamination, inaccurate dosing, unknown purity. A 2022 analysis by Cohen et al. (JAMA Internal Medicine) found significant label inaccuracy in unregulated peptide products.

If you are serious about recovery, talk to a sports medicine physician or physiotherapist. The peptide conversation, if it belongs anywhere, belongs in a clinical setting with a licensed provider, not in the comments section of an Instagram reel tied to a promo code.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Pierre-Olivier McKinnon · Instagram creator

127.5K views on this video

#gym #fitness #fitfam #prepcoach #entrainement #musculation #alimentation #pertedegras #massemusculaire #hypertrophie #entraineur #fitnesscoach #fitnessmotivation #pourtoi #stayfit #santé #miseenforme

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bpc-157 tendon healing data comes almost entirely from rat models?

BPC-157 tendon healing data comes almost entirely from rat models (Staresinic et al., 2003, Journal of Orthopaedic Research). No placebo-controlled human trial has replicated these results.

What does the video say about tb-500 has been banned by the world anti-doping agency?

TB-500 has been banned by the World Anti-Doping Agency since 2011. Competitive athletes using it risk disqualification regardless of perceived recovery benefits.

What does the video say about a 2022 jama internal medicine analysis found label inaccuracy in?

A 2022 JAMA Internal Medicine analysis found label inaccuracy in a significant proportion of unregulated peptide products, meaning you often cannot verify what you are actually injecting.

What does the video say about eccentric?

Eccentric and heavy slow resistance training protocols have stronger human evidence for tendinopathy recovery than any peptide compound currently available (Beyer et al., 2015, Scandinavian Journal of Medicine and Science in Sports).

What does the video say about neither bpc-157 nor tb-500?

Neither BPC-157 nor TB-500 is approved by the FDA or Health Canada for any human therapeutic indication. Use outside a licensed clinical trial is off-label at minimum, and illegal to sell as a therapeutic in many jurisdictions.

What does the video say about promo codes tied to peptide sales represent a commercial relationship.?

Promo codes tied to peptide sales represent a commercial relationship. Factor that into how you weigh the information being presented alongside the product.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Pierre-Olivier McKinnon, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.